No meal announcement with automated insulin delivery
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests whether an automated insulin delivery system can manage blood sugar without telling it when you eat. It combines your existing pump and continuous glucose monitor with special software, and may reduce the need for carb counting.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old and live in Canada or the U.S.
- You need to have had type 1 diabetes for at least 1 year.
- You must be using an open-source automated insulin delivery system for at least 2 weeks and a Dexcom G6 or G7 glucose monitor.
- If you use an ultra-fast insulin, you must be willing to switch to a standard fast-acting insulin for the study.
- You must agree to let the research team collect your pump settings during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a smart insulin pump and continuous glucose monitor system that adjusts insulin automatically and uses behavior support to improve blood sugar control. It's for people with type 1 diabetes who have used an approved automated insulin delivery system recently and are willing to use study devices.
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
This study tests whether an artificial intelligence (AI) system can help manage insulin pump therapy remotely for people with type 1 diabetes. The goal is to improve blood sugar control and make diabetes management easier.
This study tests whether using an automated insulin delivery system (a smart pump that adjusts insulin based on sensor readings) can help improve blood sugar control and bone health in adults with Type 1 diabetes who have high and unstable blood sugars.
This study tests a new automated insulin delivery (AID) system that connects your insulin pump to your glucose monitor to help keep your blood sugar in range. It is for both children and adults with type 1 diabetes who have not used an AID system before.
This study compares a new automated insulin delivery algorithm (AIDANET) in two modes: fully closed-loop (no user input needed) versus hybrid closed-loop (user still gives some insulin for meals). It tests how well the algorithm works in real-life settings for adults with type 1 diabetes.
Hear when a new Type 1 Diabetes (T1D) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.